HMCO5, herbal extract, inhibits NF-κB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice

Journal of Ethnopharmacology

Volumn 114, Issue 3, 2007, Pages 316-324

  Kim, Ki Mo ^a   Choi, Jin Yong ^a   Yoo, Si Eun ^a   Park, Mi Young ^a   Lee, Bok Soo ^a   Ko, Young Hye ^b   Sung, Sang Hyun ^c   Shin, Heung Mook ^d   Park, Jeong Euy ^a  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

Animal model; Atherosclerosis; Herb; HMCO5; Inflammatory cytokines; NF B

Indexed keywords

CHOLESTEROL; HMC O5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG INHIBITION; ENZYME ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; CYCLOOXYGENASE 2 INHIBITORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 35649007891     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.08.029     Document Type: Article

References (32)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12 (1994) 141-179
2. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 36 (1997) 1066-1071
3. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., and Wolfson M.F. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 20 (1997) 729-733
4. Bokoch G.M., and Knaus U.G. NADPH oxidase; not just for leukocytes anymore!. Trends in Biochemical Sciences 28 (2003) 502-508
5. Braam B., and Verhaar M.C. Understanding eNOSfor pharmacological modulation of endothelial function: a translational view. Current Pharmaceutical Design 13 (2007) 1727-1740
6. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield E.N., and Parums D.V. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Laboratory Investigation 75 (1996) 77-85
7. Dinarello C.A. Biologic basis for interleuckin-1 in disease. Blood 87 (1996) 2095-2147
8. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., and Packer L. Redox regulation of NF-kappa B activation. Free Radical Biology and Medicine 22 (1997) 1115-1126
9. Gao N., Yu S., and Xu J. Improving effect of rhizoma Gastrodiae on learning and memory of senile rats. Zhongguo Zhong Yao Za Zhi 20 (1995) 562-563
10. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96
11. Hu H.H., Tang L.X., and Li X.M. Experimental research of effect of crude and processed Herba Siegesbeckiae on anti-inflammation and anti-rheumatism. Zhongguo Zhong Yao Za Zhi 29 (2004) 542-545
12. Hur, J., 1999. (1613 a.d.). The precious mirror of oriential medicine. Dong Ui Bo Gam Seoul. Namsangdang.
13. Islam K.N., Devaraj S., and Jlalal I. Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 24 (1998) 2255-2261
14. Jun S.Y., Choi Y.H., and Shin H.M. Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells. Oncology Reports 15 (2006) 1461-1467
15. Kang S.A., Park H.J., Kim M.J., Lee S.Y., Han S.W., and Leem K.H. Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. Journal of Ethnopharmacology 97 2 (2005) 231-235
16. Karin M., and Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Seminars in Immunology 12 (2000) 85-98
17. Kim K.M., Kwon Y.G., Chung H.T., Yun Y.G., Pae H.O., Han J.A., Ha K.S., Kim T.G., and Kim Y.M. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicology and Applied Pharmacology 190 (2003) 1-8
18. Ko S.G., Lee K.S., Cho K.H., Kim Y.S., Bae H.S., and Moon S.K. Inhibition of human smooth muscle cell proliferation by gamigeonsim-tang through the transcriptional regulation of cell cycle-controlling genes. American Journal Chinese Medicine 28 (2000) 57-67
19. Lin W.C., and Lin W.L. Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World Journal of Gastroenterology 12 (2006) 265-270
20. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
21. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 (2001) 88-97
22. Napoli C., de Nigris F., William-Ignarro S., Pignalosa O., Sica V., and Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 15 (2006) 265-279
23. Park W.H., Kim S.H., Chang Y.C., Lee Y.C., and Kim C.H. The anti-platelet activity of Danggijakyaksan by inhibition of phospholipase C. Immunopharmacology and Immunotoxicology 25 (2003) 561-571
24. Rhodus N.L., Cheng B., Myers S., Bowles W., Ho V., and Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clinical Immunology 114 (2005) 278-283
25. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
26. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 340 (1999) 115-126
27. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO Journal 10 (1991) 2247-2258
28. Shin H.M., and Morgan K.G. Vasodilation by banhabackchulchunmatang, a Chinese medicine, is associated with negative modulation of PKCα activation and NO production. Life Sciences 74 (2003) 723-732
29. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., and Kostura M.J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 30 (1992) 768-774
30. Thurberg B.L., and Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Current Opinion in Lipidology 9 (1998) 387-396
31. Xie M., Lu Q., Zhu L., and Gu Z. Comparison of the effects of xianyu tablet and its component on electrophoretic mobility of serum LDL and expression of ET-1 mRNA and iNOS mRNA of vessel wall in atherosclerotic rabbits. Zhong Yao Cai 23 (2000) 474-476
32. Yokozawa T., Satoh A., Cho E.J., Kashiwada Y., and Ikeshiro Y. Protective role of Coptidis Rhizoma alkaloids against peroxynitrite-induced damage to renal tubular epithelial cells. Journal of Pharmacy Pharmacology 57 (2005) 367-374